TNF and rheumatoid arthritis: Our pipeline could be used to develop individualized therapies that identify genetic signatures to differentiate PsA treatment responses43, thus limiting the use of ineffective and unnecessary treatments, though heritability of treatment response can play a major role, as a previous attempt using genetic data to predict patients’ response to anti-TNF drugs in rheumatoid arthritis failed to improve predictive performance compared to clinical traits44.